{
    "nctId": "NCT02816762",
    "officialTitle": "Effect of Continuous Positive Airway Pressure on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea",
    "inclusionCriteria": "* Subjects aged 18 to 80 years old\n* Overweight or obesity (BMI \u226525 kg/m2)\n* Previous diagnosis of type 2 diabetes, fulfilling at least one of the following criteria: 1) current treatment with oral antidiabetic drugs and/or insulin; 2) a fasting glucose value above 126 mg/dl on at least 2 occasions; 3) blood glucose level at 2 hours after an oral glucose tolerance test is equal to or more than 200 mg/dl; or 4) a glycated hemoglobin (HbA1c) level \\> 6.5 %\n* Clinical diagnosis of diabetic nephropathy, with a urinary albumin/creatinine ratio \\>30 mg/g and an estimated glomerular filtration rate more than 20 ml/min per 1.73 m2.\n* Treatment with stable doses of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers or anti-aldosterone agents in the last four weeks.\n* Must have minimum age of 18 Years\n* Must have maximum age of 80 Years",
    "exclusionCriteria": "* Non diabetic nephropathy (confirmed by biopsy).\n* Dialysis for acute renal failure within the 6 previous months.\n* Evidence in the clinic history of relevant bilateral stenosis of renal artery (\\> 75%)\n* Urinary albumin/creatinine ratio higher than 3000 mg/g, at the baseline visit.\n* Systolic blood pressure \u2265 180 mmHg or diastolic blood pressure \u2265 110 mm Hg at the baseline visit.\n* Stroke, transient ischemic attack, acute coronary syndrome, or hospitalization for heart failure worsening, within the previous 30 days.\n* Professional drivers, risk profession or respiratory failure.\n* Severe daytime sleepiness (Epworth sleepiness scale \\>18)\n* Concomitant treatment with high doses of acetylsalicylic acid (\\> 500 mg/day) or continuous treatment with non-steroidal anti-inflammatory drugs\n* Previous treatment with CPAP\n* Participation in another clinical trial within the 30 days prior to randomization."
}